Transforming Oncology Research: IQVIA's End-to-End Patient Experience Data Approach

Oncology trials face pressure to meet evolving FDA expectations while capturing meaningful patient-experience data. IQVIA's approach combines "COA science, oncology-specific eCOA capabilities, and real-time data visibility" to help sponsors "reduce patient burden, improve compliance, and generate regulator-ready outcomes across complex oncology studies." This is largely marketing copy on a gated landing page; no specific metrics or client-level results are given without the downloadable case study.

The customer is anonymised in IQVIA’s own case study — not withheld by us.

IQVIA is the largest combined real-world-data and commercial-intelligence company in healthcare — its legacy IMS prescription and claims data underpins much of the industry's analytics.

This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.